The BRCA (BReast CAncer susceptibility) genes, BRCA1 and BRCA2, have garnered significant attention in the realm of oncology and genetic testing. Mutations in these genes are strongly associated with an increased risk of breast and ovarian cancers, prompting intensive research and the development of targeted therapies. This article delves into the dynamic landscape of the BRCA drugs market,...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian